The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase Ib study of talimogene laherparepvec (T-VEC) injection into liver metastases (LMs) in combination with intravenous (IV) atezolizumab in patients (pts) with metastatic triple-negative breast cancer (TNBC) or colorectal cancer (CRC).
 
J. Randolph Hecht
Stock and Other Ownership Interests - Actym Therapeutics
Consulting or Advisory Role - Aduro Biotech; Amgen; ARMO BioSciences; Bristol-Myers Squibb; Cornerstone; Gritstone Bio; Halozyme; Merck; Roche
Research Funding - ADVARIS; Amgen; ARMO BioSciences; Halozyme; Merck; Merrimack
 
Arlene Chan
Honoraria - Eisai; Novartis
Speakers' Bureau - Prime Oncology
Research Funding - Eisai
Travel, Accommodations, Expenses - Pierre Fabre
 
Miguel Martin
Consulting or Advisory Role - Lilly; Novartis; Pfizer; Roche/Genentech
Research Funding - Novartis (Inst); Roche (Inst)
 
Nicolas Mach
Stock and Other Ownership Interests - MaxiVax
Honoraria - Bristol-Myers Squibb
Consulting or Advisory Role - Amgen; AstraZeneca; Bristol-Myers Squibb; MSD; Roche
Research Funding - MaxiVax (Inst)
 
Sara A. Hurvitz
Research Funding - Ambryx (Inst); Amgen (Inst); Bayer (Inst); Biomarin (Inst); Boehringer Ingelheim (Inst); Cascadian Therapeutics (Inst); Daiichi Sankyo (Inst); Dignitana (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Lilly (Inst); Macrogenics (Inst); Medivation (Inst); Merrimack (Inst); Novartis (Inst); OBI Pharma (Inst); Pfizer (Inst); Puma Biotechnology (Inst); sanofi (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - Lilly; Novartis; OBI Pharma
 
Sylvie Rottey
No Relationships to Disclose
 
Uwe Pelzer
No Relationships to Disclose
 
Chunxu Liu
Employment - Amgen
Stock and Other Ownership Interests - Amgen
 
Emily Chan
Employment - Amgen
Stock and Other Ownership Interests - Amgen